Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Added, NewsWith a mission to redefine what gene therapy can do, Spur is optimizing every component of its product candidates to develop a new generation of gene therapies
Spur is advancing two potentially life-changing gene therapy candidates in clinical…
Freeline to Participate in Upcoming Investor Conferences
AddedLONDON, July 31, 2023 – Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the company will be participating in two upcoming investor conferences in August. Details are as follows:
BTIG Virtual Biotechnology Conference
Freeline…
